Effect of Unani drug (shoniz with sirka) on Buthur labanniya (Acne vulgaris)

Phase 2

Not yet recruiting

Conditions: Acne vulgaris,

Registration Number: CTRI/2020/06/025718

Lead Sponsor: Central Council for Research in Unani MedicineNew Delhi

Brief Summary: Buthur labanniya (Acne vulgaris) is a chronic inflammatory disease of pilosebaceous unit presenting with seborrhoea, open and closed comedones, papules, pustules and nodulocystic lesions in severe cases. It affects primarily the face, neck, upper trunk and upper arms. It has been estimated that 70% of general population have some clinically evident acne at some stage during adolescence. As per classical Unani literature, Buthur labanniya are tiny white eruptions on nose and cheeks which resemble with condensed milk droplets. These are caused by suppurative matter which comes to the surface of skin due to bukharat (vapours) of the body.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

1.Clinically stable patients of Buthur labanniya 2.Patients having comedones,papules,pustules,itching and erythema 3.Patients willing to give consent 4.Patients irrespective of gender 5.Patients in the age group of 10 to 40 years.

Exclusion Criteria

1.Patients below the age of 10 and above the age of 40 2.Pregnant females 3.Lactating mothers 4.Mentally retarded persons 5.Patients with severe acne 6.Patients on corticosteroid therapy,anticonvulsant therapy or taking oral contraceptives 7.Patients suffering from other concomitant diseases like acne rosacea,acne fulminans,acne necrotica,psoriasis or eczema etc 8.Patients diagnosed of PCOS 9.Patients with diabetes mellitus,chronic kidney disease and chronic liver disease 10.Patients with thyroid disease 11.History of allergy to Benzoyl Peroxide 13.Patients who fail to give consent 14.Patients who have used any anti acne treatment in last 30 days.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in signs and symptoms of acne vulgaris (Buthur labanniya)	2 to 8 weeks

Secondary Outcome Measures

Name	Time	Method
Haematological and biochemical assessment for safety	2 to 8 weeks

Trial Locations

Locations (1): Regional Research Institute of Unani Medicine
🇮🇳
JAMMU, & KASHMIR, India
Regional Research Institute of Unani Medicine
🇮🇳JAMMU, & KASHMIR, India
Dr Gousia Mehraj
Principal investigator
9596123062
gousianizami00@gmail.com